User profiles for J. ROSENBERG

Jonathan Rosenberg

- Verified email at mskcc.org - Cited by 43872

Jonathan Rosenberg

- Verified email at jdrosen.net - Cited by 35557

The minimally conscious state: definition and diagnostic criteria

…, B Jennett, DI Katz, JP Kelly, JH Rosenberg, J Whyte… - Neurology, 2002 - AAN Enterprises
Objective: To establish consensus recommendations among health care specialties for defining
and establishing diagnostic criteria for the minimally conscious state (MCS). Background…

Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the …

RG Miller, JA Rosenberg, DE Gelinas… - … and neural repair, 1999 - journals.sagepub.com
As with other chronic neurologic diseases, many of the problems engendered by the disease
can be managed effectively with a beneficial impact on quality of life and m some mstances …

Diagnosis and management of concussion in sports

JP Kelly, JH Rosenberg - Neurology, 1997 - AAN Enterprises
Any sport has an inherent risk of injury. A balance must be reached between maintaining a
competitive edge in a sport and ensuring participant safety. Frequently the loss of objectivity …

[PDF][PDF] IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

…, TM Liles, I Royston, C Varns, J Rosenberg… - Journal of clinical …, 1997 - io.ctdm.org.cn
Purpose: To evaluate the safety, pharmacokinetics, andbiologic effect of multiple doses of
the chimeric anti-CD20 monoclonal antibody (mAb) IDEC-C2B8 in patients with relapsed B-…

Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment

…, DG Maloney, RL Weaver, J Rosenberg… - Journal of clinical …, 2000 - ascopubs.org
PURPOSE: This phase II trial investigated the safety and efficacy of re-treatment with rituximab,
a chimeric anti-CD20 monoclonal antibody, in patients with low-grade or follicular non-…

[PDF][PDF] Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and …

…, MR Grever, AJ Grillo-Lopez, J Rosenberg… - Journal of Clinical …, 2001 - Citeseer
Purpose: Rituximab has been reported to have little activity in small lymphocytic lymphoma (SLL)/chronic
lymphocytic leukemia (CLL) and to be associated with significant infusion-…

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

JL Rubenstein, D Combs, J Rosenberg… - Blood, The Journal …, 2003 - ashpublications.org
Most lymphomas that involve the central nervous system are B-cell neoplasms that express
the cell surface molecule CD20. After intravenous administration, rituximab can be …

Using electroencephalography to study functional coupling between cortical activity and electromyograms during voluntary contractions in humans

DM Halliday, BA Conway, SF Farmer, JR Rosenberg - Neuroscience letters, 1998 - Elsevier
Previous studies of neuronal oscillations in sensorimotor cortex in humans and primates have
observed rhythmic 15–30 Hz activity, which is correlated with motor output. In humans, this …

An extended difference of coherence test for comparing and combining several independent coherence estimates: theory and application to the study of motor units …

AM Amjad, DM Halliday, JR Rosenberg… - Journal of neuroscience …, 1997 - Elsevier
Recently there has been an increase in the use of spectral methods for the analysis of
experimental data. These analytical methods allow the study of interactions between …

Towards a proteome-scale map of the human protein–protein interaction network

…, C Simon, M Boxem, S Milstein, J Rosenberg… - Nature, 2005 - nature.com
Systematic mapping of protein–protein interactions, or ‘interactome’ mapping, was initiated
in model organisms, starting with defined biological processes 1 , 2 and then expanding to …